The terms used herein, unless the context otherwise stated, bear the same meaning as those defined in the earlier announcements in relation to the Corporate Exercises.

We refer to the earlier announcements dated 10 April 2026, 24 April 2026, 10 June 2026, 11 June 2026, 29 July 2026, 11 August 2026 and 12 August 2026 in relation to the Corporate Exercises.

On behalf of the Board, UOBKH wishes to announce that as at the close of acceptance, excess application and payment for the Rights Issue with Warrants as at 5.00 p.m. on Friday, 28 August 2026, the total acceptances and excess applications for the Rights Issue with Warrants were 150,110,157 Rights Shares, which represents an over-subscription of 104.00% over the total number of 73,583,679 Rights Shares available for subscription under the Rights Issue with Warrants, the details of which are set out below:-

Successful applicants of the Rights Shares will be given Warrants on the basis of 1 Warrant for every 1 Rights Share successfully subscribed for.

It is the intention of the Board to allot the excess Rights Shares with Warrants, if any, in a fair and equitable basis. The Board has applied the following basis and priority in allocating the excess Rights Shares with Warrants, in accordance with the Abridged Prospectus dated 12 August 2026:-

i. firstly, to minimise the incidence of odd lots of Rights Shares;

ii. secondly, on a pro-rata basis and in board lots, to the Entitled Shareholders who have applied for the Excess Rights Shares with Warrants, taking into consideration their respective shareholdings in the Company as at the Entitlement Date;

iii. thirdly, on a pro-rata basis and in board lots, to the Entitled Shareholders who have applied for Excess Rights Shares with Warrants, taking into consideration the quantum of their respective Excess Rights Shares with Warrants; and

iv. finally, on a pro-rata basis and in board lots, to the renouncee(s) and/ or transferee(s) (if applicable) who have applied for Excess Rights Shares with Warrants, taking into consideration the quantum of their respective Excess Rights Shares with Warrants.

The Excess Rights Shares with Warrants will firstly be allocated to minimise the odd lots of Rights Shares (if any) held by each applicant of the Excess Rights Shares with Warrants. Thereafter, the allocation process will perform items (ii), (iii) and (iv) in succession. Any remaining balance of the Excess Rights Shares with Warrants will be allocated by performing the same sequence of allocation i.e., items (ii), (iii) and (iv) again in succession until all Excess Rights Shares with Warrants are allotted.

Notwithstanding the foregoing, the Board reserves the right to allot any Excess Rights Shares with Warrants applied for under Part I(B) of the RSF in such manner as it deems fit and expedient and in the best interests of the Company, subject always to such allocation being made on a fair and equitable basis, and that the intention of the Board as set out in step (i) to (iv) above is achieved. The Board also reserves the right at its absolute discretion not to accept any Excess Rights Shares with Warrants, in full or in part, without assigning any reason thereto.

The Rights Shares and Warrants are expected to be listed on the Main Market of Bursa Securities on 14 September 2026.

This announcement is dated 7 September 2026.